4-Bromocinnamic acid, predominantly trans, 97+%
4-Bromocinnamic acid, predominantly trans, 97+%
4-Bromocinnamic acid, predominantly trans, 97+%
Thermo Scientific Chemicals

4-Bromocinnamic acid, predominantly trans, 97+%

CAS: 1200-07-3 | C9H7BrO2 | 227.06 g/mol
Have Questions?
變更視圖buttonViewtableView
Quantity:
5 g
25 g
100 g
產品號碼 A11503.14
亦稱為 A11503-14
價格 (TWD)
-
Quantity:
25 g
Request bulk or custom format
化學識別
CAS1200-07-3
IUPAC Name(2E)-3-(4-bromophenyl)prop-2-enoic acid
Molecular FormulaC9H7BrO2
InChI KeyCPDDDTNAMBSPRN-ZZXKWVIFSA-N
SMILESOC(=O)C=CC1=CC=C(Br)C=C1
檢視更多
規格Specification Sheet規格表
Melting Point (clear melt)259.5-265.5°C
FormCrystals or powder or crystalline powder
Assay (Silylated GC)≥97.0%
Appearance (Color)White
Assay (Aqueous acid-base Titration)≥97.0 to ≤103.0%
4-Bromocinnamic acid has been used in the preparation of: (E)-β-bromo-4-bromostyrene, 2-amino-7-(piperidin-4-yl)isoquinoline, brominated dansyl derivative (4-bromophenyl)-4-(5-(dimethylamino)naphthalene-1-sulfonamido)butanoic acid.

This Thermo Scientific Chemicals brand product was originally part of the Alfa Aesar product portfolio. Some documentation and label information may refer to the legacy brand. The original Alfa Aesar product / item code or SKU reference has not changed as a part of the brand transition to Thermo Scientific Chemicals.

Applications
4-Bromocinnamic acid has been used in the preparation of: (E)-β-bromo-4-bromostyrene, 2-amino-7-(piperidin-4-yl)isoquinoline, brominated dansyl derivative (4-bromophenyl)-4-(5-(dimethylamino)naphthalene-1-sulfonamido)butanoic acid.

Solubility
Soluble in alcohol, ethyl acetate, DMSO. Insoluble in water.

Notes
Store at -20°C. Store in a cool, dry, well-ventilated area away from incompatible substances such as oxidizing agents.
RUO – Research Use Only
Jane L. R. Yates and Hazel A. Sparkes. 4-Bromo-trans-cinnamic acid: structural characterization and crystallographic investigation into the solid state [2 + 2] cycloaddition reaction and temperature induced phase transition. CrystEngComm.2013, 15 3547-3553.